Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target? - sprookjes - yvandenbroek - TriplyDB

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

http://www.wikidata.org/entity/Q33797190

about

Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress Role of the MPTP in conditioning the heart - translatability and mechanism Metabolic methanol: molecular pathways and physiological roles Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells Identification of εPKC targets during cardiac ischemic injury Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12.Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activation Mitochondrial aldehyde dehydrogenase and cardiac diseases.Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling.Acetaldehyde adducts in alcoholic liver disease.Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function.Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.Impaired cardiac SIRT1 activity by carbonyl stress contributes to aging-related ischemic intolerance.ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications.Differential effects of organic nitrates on arterial diameter among healthy Japanese participants with different mitochondrial aldehyde dehydrogenase 2 genotypes: randomised crossover trial.Nitric oxide-mediated coronary flow regulation in patients with coronary artery disease: recent advances.PKC-ALDH2 Pathway Plays a Novel Role in Adipocyte Differentiation.Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction.Cardiac Mitochondrial Respiratory Dysfunction and Tissue Damage in Chronic Hyperglycemia Correlate with Reduced Aldehyde Dehydrogenase-2 Activity Nitroglycerin use in myocardial infarction patients Effects of caloric restriction on cardiac oxidative stress and mitochondrial bioenergetics: potential role of cardiac sirtuins.Effect of aldehyde dehydrogenase 2 gene polymorphism on hemodynamics after nitroglycerin intervention in Northern Chinese Han population.DNA damage and neurotoxicity of chronic alcohol abuse ALDH2 protects against stroke by clearing 4-HNE.Activation of ALDH2 with Low Concentration of Ethanol Attenuates Myocardial Ischemia/Reperfusion Injury in Diabetes Rat Model Monoamine Oxidase Is Overactivated in Left and Right Ventricles from Ischemic Hearts: An Intriguing Therapeutic Target.Reduced aldehyde dehydrogenase expression in preeclamptic decidual mesenchymal stem/stromal cells is restored by aldehyde dehydrogenase agonists.Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease.The "Goldilocks Zone" from a redox perspective-Adaptive vs. deleterious responses to oxidative stress in striated muscle.Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models.Cardiac mitochondrial proteomic expression in inbred rat strains divergent in survival time after hemorrhage.Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function.Inhibition of ALDH2 expression aggravates renal injury in a rat sepsis syndrome model Regulation of human mitochondrial aldehyde dehydrogenase (ALDH-2) activity by electrophiles in vitro.ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress.Aldehyde Dehydrogenase 2 (ALDH2) Glu504Lys Polymorphism Affects Collateral Circulation and Short-Term Prognosis of Acute Cerebral Infarction Patients Characterization of cardiac-resident progenitor cells expressing high aldehyde dehydrogenase activity.

P2860

Q26799354-295A687B-284B-42E6-A04C-60D0F72D168D Q26830560-DA4FA3B5-F263-473E-B154-D4D08495C1BA Q27000276-23626F29-4A1B-4373-8D9A-D51A21C815B5 Q28078884-797105A9-FBAE-4395-B4C0-E85DF7C6D817 Q28262921-FF70051F-D4EA-44BC-952C-673984B29C78 Q28265682-5CAB9602-3892-4F9B-A50A-B41DB6EE0A89 Q28391033-7B57E90B-BF2F-449B-87D3-EE25D33224F3 Q30410768-15BBC7CD-4B1A-4565-8CC9-2F9E074276DD Q33603610-D3E7D89A-955C-4BE1-9802-5180EA23F9FF Q34113383-8925A839-00BE-4146-9F0E-D0A392385F5A Q34137983-8B25305D-FE5E-4C04-8B93-C019F7E31E9C Q34185763-E3F292D2-9972-4E63-848B-9ADCC2BA245F Q34242002-D328A3E6-3C1A-4B8F-8376-81EF3473481A Q34395219-B37342D1-C64D-4FE6-95F8-E899445D87BC Q34989691-2BE9EAA8-6D65-4597-8291-F7C3F4BACB51 Q35129038-B78F1C5C-A1CC-4ABD-B2AB-D3BDE3E6C209 Q35320191-EE4627AC-8D05-4C55-B7CE-2EE269475088 Q35902581-06B0FFCF-F526-4469-8F46-A8DC13DF5314 Q36117113-6532B0A3-6A55-4892-87FD-541AC6AE9CE2 Q36130961-E761B783-842B-4E90-B726-35A723962133 Q36162437-E695048D-2251-411C-8A73-522940125F00 Q36480060-E9F0233B-B353-4E52-ABEB-AA55490B5EF1 Q36733858-390459E3-DF24-439C-96D3-935FC6CDDD0E Q36816293-3EEC4DD3-9BA0-43E1-AD8A-0EA1E6067219 Q36937215-EA16EA9D-0FAA-4DAD-8077-C117CAC3CBD8 Q36973943-6DE9D89D-98A6-4CC4-9C04-00ACCF68D3AD Q37382697-FD7D8057-4A1A-47F6-90E9-396AFEB26C5F Q37504039-7D19FE4D-A876-40A5-B498-F1E6F1540130 Q37638211-97EB8425-1DA6-42A7-86D8-854B752DE0C6 Q38163001-0AD0AA34-7B7E-4735-A36E-EC33731B805B Q38256368-6D0EF785-FF8A-4A89-9FFA-389926D4687F Q39446080-CF3257BA-B271-45FB-A62B-E95A8515AA7C Q39471860-4BC85165-4A43-4B17-AB09-CD9B673DF631 Q39669262-5B1F0817-9050-404B-8682-98E26CD1D185 Q41089202-41F106E7-E738-46A6-B944-B280A5F659A6 Q41672296-4FFC581F-0A1A-49D2-9AD2-A495E3BEAE28 Q41932170-D7371BE8-A34E-4944-B5A5-DD7C81EBFE4B Q42061022-BBAACA69-DD09-44CE-BAD0-4485D42E9440 Q42275836-60938B9B-292F-481B-A075-1E178B277048 Q43240830-8F610438-DE01-403A-BCC5-E3396DD581E4

P2860

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

http://www.wikidata.org/entity/Q33797190

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

@ast

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

@en

type

label

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

@ast

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

@en

prefLabel

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

@ast

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

@en

P1433

Q33797190-F30BC4AC-ED50-4CB3-9915-05EF69251A5F

P1476

Q33797190-C0F6CB9B-06CA-48B8-AD80-2C00E40892AC

P2093

Q33797190-06138AEA-24D2-485C-82EE-29289A20A54C

Q33797190-BA6D2706-00E7-4ECB-BBBF-8A822A303EBE

P2860

Q33797190-04DE1A76-0E0E-4FCF-BF16-8A154FF6CF5D

Q33797190-07EBEF4F-2A3F-41BB-8FD8-D9F8E14DB2A3

Q33797190-08A1AC50-0EAC-4E96-A5C2-7A452DD716EE

Q33797190-0ED558E3-55E8-4F7F-9DC6-45D189CDB853

Q33797190-16F3395C-E2CD-4C76-9F33-0199AD7B9879

Q33797190-317B002A-7AE9-475B-BD22-F1C6F0ECD887

Q33797190-33017063-DF19-4464-B7FC-9BBC8232E518

Q33797190-338AC184-B125-430A-8080-6252BDFEA826

Q33797190-34F62295-A156-44D5-AE84-DF00384A6B9E

Q33797190-35608154-38FE-45DE-B5FC-5D10ABD99E78

P304

Q33797190-47719F92-9A67-44A3-92F8-F6526C2905D2

P31

Q33797190-58765516-0969-4421-A37A-32871B7FF369

P356

Q33797190-A5ADE36B-CBD1-4301-BD78-F88671BA5E3C

P433

Q33797190-572800E6-0EAF-466E-B4BC-8676F6D78FB5

P478

Q33797190-BC66DC32-9695-4DE3-BD5A-C59332463474

P50

Q33797190-DE7E9596-B759-43D4-A610-76018CEE1387

P577

Q33797190-32DD3600-0993-4FE0-B529-C2B2FCCE523D

P5875

Q33797190-59F3FBB5-3F5F-48CF-A970-8B330037DF14

P698

Q33797190-62160574-219C-4490-A79D-E619CB697D23

P932

Q33797190-14F163BF-B857-4D27-8CFA-F64319E39EC5

P356

J.TCM.2009.09.003

P1433

Trends in Cardiovascular Medicine

P1476

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

@en

P2093

Grant R Budas

http://www.w3.org/2001/XMLSchema#string

Marie-Hélène Disatnik

http://www.w3.org/2001/XMLSchema#string

P2860

An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation

Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria

Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart

Nitric oxide: physiology, pathophysiology, and pharmacology

Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes

Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation

Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity

Preconditioning protects ischemic rabbit heart by protein kinase C activation

P304

158-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TCM.2009.09.003

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Daria Mochly-Rosen

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40683289

http://www.w3.org/2001/XMLSchema#string

P698

20005475

http://www.w3.org/2001/XMLSchema#string

P932

2856486

http://www.w3.org/2001/XMLSchema#string